Blueprint Medicines Corp Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Blueprint Medicines Corp Stock
So far the community has only identified positive things for Blueprint Medicines Corp stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Blueprint Medicines Corp in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Blueprint Medicines Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | 1.550% | 0.000% | 18.072% | 105.236% | 18.072% | 180.000% | 61.383% |
| United Therapeutics | 1.150% | -0.653% | -5.142% | 82.534% | 13.971% | 133.014% | 186.471% |
| Ionis Pharmaceuticals Inc. | 0.220% | 0.505% | 0.727% | 135.377% | -6.210% | 98.629% | 78.894% |
News
Spirits on the Rocks? The Battle for Jack Daniels
The global premium spirits sector is navigating a significant shift. After a period of high consumer demand driven by COVID-era stay-at-home trends, the market is now normalizing. This return to
Irresistible Change: How to Spot Real Growth
Phil Gilbert, serial entrepreneur and former general manager at IBM, joins this episode of Motley Fool Money to talk about his new book, Irresistible Change: A Blueprint for Earning Buy-In and
Offshore Titans: Transocean Buys Valaris for $5.8B
Transocean Ltd. (NYSE: RIG) has made the definitive move to cement its status as the undisputed leader in offshore drilling. By agreeing to acquire Valaris Limited (NYSE: VAL) in an all-stock